18 search results for: barrier dysfunction

Type 2 Inflammation and Sinonasal <b>Barrier</b> <b>Dysfunction</b> in CRSwNP
Rhinology
Type 2 Inflammation and Sinonasal Barrier Dysfunction in CRSwNP
videoanimation

Explore how type 2 inflammation drives sinonasal barrier dysfunction in chronic rhinosinusitis with nasal polyps (CRSwNP) with this video on the cellular mechanisms behind hallmark symptoms — including nasal congestion and loss of smell.

View more
CRSwNP Triathlon: An Interactive Learning Experience
Rhinology
CRSwNP Triathlon: An Interactive Learning Experience
interactivity

Embark on this interactive triathlon challenge to uncover the interplay of type 2 inflammation, barrier dysfunction, and neuroimmune dysregulation in the disease pathology of CRSwNP.

View more
Skin <b>Barrier</b> <b>Dysfunction</b> in AD
Dermatology
Skin Barrier Dysfunction in AD
expert video

In this highlight video from the May 2024 ADVENT symposium at ESPD’s Annual Meeting in Košice, Slovakia, Dr. Lisa Weibel discusses how type 2 inflammation contributes to epidermal barrier dysfunction and AD signs and symptoms.

View more
<b>Barrier</b> disruption in AD and the development of environmental and food allergies
Dermatology
Barrier disruption in AD and the development of environmental and food allergies
expert video

Dr. Casale discusses the critical role of barrier disruption in atopic dermatitis

View more
Role of Type 2 Inflammation in Skin <b>Barrier</b> Disruption and Itch
Dermatology
Role of Type 2 Inflammation in Skin Barrier Disruption and Itch
expert video

In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert discusses how type 2 inflammation contributes to epidermal barrier dysfunction and chronic itch in AD

View more
Exploring the Potential Disease-Modifying Approaches in AD
Dermatology
Exploring the Potential Disease-Modifying Approaches in AD
interactivity

Explore the concept of disease modification in atopic dermatitis through this interactive infographic, which highlights potential considerations such as optimal sustained disease control, subclinical inflammation, the pathophysiology of AD, and atopic/non-atopic comorbidities.

View more
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
Pulmonology
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
expert video

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

View more
Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video
Pulmonology
Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video
videoanimation

Learn about the significant burden that patients with COPD experience and the role of inflammatory mechanisms in this chronic, often progressive disease. 

View more
The Cycle of Inflammation in Adult Asthma
Pulmonology
The Cycle of Inflammation in Adult Asthma
interactivity

Explore the role of chronic type 2 inflammation in the cycle of exacerbations and worsening lung function in patients with asthma.

View more
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
Pulmonology
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
expert video

Dr. Reynold Panettieri discusses how IL-4 and IL-13 drive airway remodeling in type 2 asthma.

View more
Diving Below the Surface of AD: The Role of Type 2 Inflammation
Dermatology
Diving Below the Surface of AD: The Role of Type 2 Inflammation
expert video

This video from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, features Dr. Stephan Weidinger discussing how local type 2 inflammation at the skin tissue level contributes to epidermal barrier dysfunction, dysbiosis, and neuroimmune dysfunction, leading to the clinical signs and symptoms of AD. Dr. Weidinger also reviews how systemic inflammation affects organ systems beyond the skin and can manifest as atopic and non-atopic comorbidities.

View more
Within and Beyond the Skin: New Perspectives on the Role of Type 2 Inflammation in AD
Dermatology
Within and Beyond the Skin: New Perspectives on the Role of Type 2 Inflammation in AD
expert video

This video from the May 2024 ADVENT symposium at ESPD’s Annual Meeting in Košice, Slovakia features Dr. Lisa Weibel presenting how local type 2 inflammation within the skin contributes to epidermal barrier dysfunction, dysbiosis, and neuroimmune dysfunction, leading to the clinical signs and symptoms of AD. Dr. Weibel also reviews how systemic inflammation affects organ systems beyond the skin, and could potentially manifest as atopic and non-atopic comorbidities.

View more